FIBA company, Aeye Health, receives FDA clearanceThe Tel Aviv-based healthtech firm AEYE Health announced on Tuesday it has received clearance from the U.S. Food & Drug Administration to market its diagnostic screening system for diabetic retinopathy, a complication of diabetes caused by high blood sugar levels that can damage the retina and cause blindness if left undiagnosed. Instead of needing an annual appointment with an ophthalmologist for screening, AEYE patients will be able to receive initial screening from their primary care physician or at other healthcare facilities including retail pharmacies. Only patients for which the AI system detects potential disease need to be referred to a specialist. That clearance could be a game-changer for the millions of people who are at high risk of diabetic retinopathy (a condition that remains the top cause of blindness in the working-age population).
Read the full story: https://www.fastcompany.com/90811773/aeye-health-gets-fda-clearance-to-use-ai-to-screen-diabetics-in-hopes-of-preventing-blindness
Chris Sullivan: Becoming the face of Outback Steakhouse
March 4, 2023 4:45 pm
Crabby Bill’s, Teak owners share playbook on retaining talent
March 2, 2023 4:44 pm
Turned Tides: Employers feeling privileged that employees even glance their way
March 1, 2023 4:44 pm
Molekule Expands its Industry-Leading Portfolio of Indoor Air Quality (IAQ) Solutions Technology with Definitive Agreement to Acquire Aura Smart Air Ltd.
February 23, 2023 4:41 pm
The links between Miami and Israel's high tech
January 11, 2023 10:39 am